Intensive Sequential Chemotherapy With Adriamycin Taxol and Cytoxan in the Treatment of Locally Advanced Breast Cancer.

Trial Profile

Intensive Sequential Chemotherapy With Adriamycin Taxol and Cytoxan in the Treatment of Locally Advanced Breast Cancer.

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 09 Jun 2015

At a glance

  • Drugs Cyclophosphamide (Primary) ; Doxorubicin (Primary) ; Paclitaxel (Primary)
  • Indications Advanced breast cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 11 Dec 2011 Planned number of patients 100 added as reported by ClinicalTrials.gov.
    • 11 Dec 2011 Planned End Date 1 Sep 2013 added as reported by ClinicalTrials.gov.
    • 09 Oct 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top